Title |
Major milestones in translational oncology
|
---|---|
Published in |
BMC Medicine, July 2016
|
DOI | 10.1186/s12916-016-0654-y |
Pubmed ID | |
Authors |
Tommaso A. Dragani, Antoni Castells, Vathany Kulasingam, Eleftherios P. Diamandis, Helena Earl, Wade T. Iams, Christine M. Lovly, J. P. Michiel Sedelaar, Jack A. Schalken |
Abstract |
Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. Today, translational research in oncology benefits from an abundance of knowledge resulting from genome-scale studies regarding the molecular pathways involved in tumorigenesis. In this Forum article, we highlight the state of the art of translational oncology in five major cancer types. We illustrate the use of molecular profiling to subtype colorectal cancer for both diagnosis and treatment, and summarize the results of a nationwide screening program for ovarian cancer based on detection of a tumor biomarker in serum. Additionally, we discuss how circulating tumor DNA can be assayed to safely monitor breast cancer over the course of treatment, and report on how therapy with immune checkpoint inhibitors is proving effective in advanced lung cancer. Finally, we summarize efforts to use molecular profiling of prostate cancer biopsy specimens to support treatment decisions. Despite encouraging early successes, we cannot disregard the complex genetics of individual susceptibility to cancer nor the enormous complexity of the somatic changes observed in tumors, which urge particular attention to the development of personalized therapies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 29% |
Italy | 1 | 14% |
United States | 1 | 14% |
Australia | 1 | 14% |
Unknown | 2 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 57% |
Scientists | 2 | 29% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 1 | <1% |
Italy | 1 | <1% |
Unknown | 105 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 16% |
Student > Ph. D. Student | 14 | 13% |
Student > Master | 14 | 13% |
Student > Bachelor | 8 | 7% |
Other | 8 | 7% |
Other | 21 | 20% |
Unknown | 25 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 27% |
Biochemistry, Genetics and Molecular Biology | 15 | 14% |
Nursing and Health Professions | 8 | 7% |
Agricultural and Biological Sciences | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Other | 12 | 11% |
Unknown | 31 | 29% |